Agbarya A - Search Results

1

Treatment of Rare Mutations in Patients with Lung Cancer.

Taha T, Khoury R, Brenner R, Nasrallah H, Shofaniyeh I, Yousef S, Agbarya A. Taha T, et al. Among authors: agbarya a. Biomedicines. 2021 May 11;9(5):534. doi: 10.3390/biomedicines9050534. Biomedicines. 2021. PMID: 34064757 Free PMC article. Review.

2

Hormone dependent metastatic salivary gland carcinoma: a case report.

Agbarya A, Billan S, Nasrallah H, Dvir A, Soussan-Gutman L, Kaidar-Person O. Agbarya A, et al. Springerplus. 2014 Jul 16;3:363. doi: 10.1186/2193-1801-3-363. eCollection 2014. Springerplus. 2014. PMID: 25077066 Free PMC article.

3

Getting out of a wheelchair: an uncommon insertion mutation in exon 19 of EGFR responsive to erlotinib.

Agbarya A, Melamed-Frank M, Kaidar-Person O, Goldberg-Cohen I, Nasrallah H, Wollner M, Bar J, Rennert G, Lejbkowicz F. Agbarya A, et al. Springerplus. 2014 Sep 9;3:507. doi: 10.1186/2193-1801-3-507. eCollection 2014. Springerplus. 2014. PMID: 25279299 Free PMC article.

4

Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.

Epelbaum R, Shacham-Shmueli E, Klein B, Agbarya A, Brenner B, Brenner R, Gez E, Golan T, Hubert A, Purim O, Temper M, Tepper E, Voss A, Russell K, Dvir A, Soussan-Gutman L, Stemmer SM, Geva R. Epelbaum R, et al. Among authors: agbarya a. Biomed Res Int. 2015;2015:681653. doi: 10.1155/2015/681653. Epub 2015 May 28. Biomed Res Int. 2015. PMID: 26161408 Free PMC article.

5

Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort.

Dudnik E, Bar J, Peled N, Bshara E, Kuznetsov T, Cohen AY, Shochat T, Nechushtan H, Onn A, Agbarya A, Moskovitz M, Keren S, Popovits-Hadar N, Urban D, Mishaeli M, Rabinovich NM, Brenner R, Zer A, Rotem O, Roisman LC, Wollner M; Israel Lung Cancer Group. Dudnik E, et al. Among authors: agbarya a. Clin Lung Cancer. 2019 Jul;20(4):278-286.e1. doi: 10.1016/j.cllc.2019.03.007. Epub 2019 Apr 5. Clin Lung Cancer. 2019. PMID: 31060855

6

[MANAGING LUNG CANCER PATIENTS' CARE DURING THE COVID-19 PANDEMIC].

Agbarya A, Khoury R, Nasser NJ, Lazri S, Volovik I, Gorenberg M. Agbarya A, et al. Harefuah. 2020 Jul;159(7):470-474. Harefuah. 2020. PMID: 32720761 Hebrew.

7

[TREATMENT OF ONCOLOGY PATIENTS DURING THE CORONA VIRUS ERA].

Khoury R, Gorenberg M, Lazri S, Amromin T, Kozlener E, Agbarya A. Khoury R, et al. Among authors: agbarya a. Harefuah. 2020 Dec;159(12):861-866. Harefuah. 2020. PMID: 33369298 Hebrew.

8

Encephalitis Induced by Durvalumab During Treatment of Metastatic Small-Cell Lung Cancer: Illustrative Case and Review of the Literature.

Shechtman Y, Shalata W, Khoury R, Mahajna A, Weller B, Agbarya A. Shechtman Y, et al. Among authors: agbarya a. J Immunother. 2021 Sep 1;44(7):243-247. doi: 10.1097/CJI.0000000000000362. J Immunother. 2021. PMID: 33734140 Review.

9

Anti-androgen for myoepithelial tumor: a potent therapy yet a potential misleader.

Hijab A, Taha T, Charas T, Bar-Sela G, Stein P, Agbarya A. Hijab A, et al. Among authors: agbarya a. Anticancer Drugs. 2022 Jan 1;33(1):e747-e751. doi: 10.1097/CAD.0000000000001175. Anticancer Drugs. 2022. PMID: 34387605

10

Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs.

Agbarya A, Sarel I, Ziv-Baran T, Agranat S, Schwartz O, Shai A, Nordheimer S, Fenig S, Shechtman Y, Kozlener E, Taha T, Nasrallah H, Parikh R, Elkoshi N, Levy C, Khoury R, Brenner R. Agbarya A, et al. Cancers (Basel). 2021 Aug 20;13(16):4191. doi: 10.3390/cancers13164191. Cancers (Basel). 2021. PMID: 34439346 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page